Mark Jason Heath Ellison

Insider Reports History

Entity
Individual
Location
C/O Opiant Pharmaceuticals, Inc., 201 Santa Monica Blvd., Suite 500, Santa Monica, CA
Signature
/s/ Mark Jason Heath Ellison
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Jason Heath Ellison:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Common Stock 0 $20.00 Mar 2, 2023 Indirect
OPIANT PHARMACEUTICALS, INC. Chief Development Officer Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct

Insider Reports Filed by Mark Jason Heath Ellison

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 8 -$609K 4 Mar 3, 2023 Chief Development Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2023 1 -$12.4K 4 Jan 31, 2023 Chief Development Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 9, 2023 1 -$9.47K 4 Jan 9, 2023 Chief Development Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 5, 2023 1 -$36.5K 4 Jan 5, 2023 Chief Development Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jun 27, 2022 1 $0 4 Jun 29, 2022 Chief Development Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 4, 2022 1 $0 4 Jan 5, 2022 Chief Development Officer